February 2013 - Volume 19 - Issue 2
pp: 221-460,E12-E31

Evaluation of Responsive Gene Expression as a Sensitive and Specific Biomarker in Patients with Ulcerative Colitis

Román, Juan; Planell, Núria; Lozano, Juan J.; More

Inflammatory Bowel Diseases. 19(2):221-229, February 2013.

Phenotype–Genotype Profiles in Crohn's Disease Predicted by Genetic Markers in Autophagy-Related Genes (GOIA Study II)

Durães, Cecília; Machado, José C.; Portela, Francisco; More

Inflammatory Bowel Diseases. 19(2):230-239, February 2013.

Genetic Susceptibility in IBD: Overlap Between Ulcerative Colitis and Crohn's Disease

Doecke, James D.; Simms, Lisa A.; Zhao, Zhen Zhen; More

Inflammatory Bowel Diseases. 19(2):240-245, February 2013.

Neutralization of Membrane TNF, but Not Soluble TNF, Is Crucial for the Treatment of Experimental Colitis

Perrier, Clémentine; de Hertogh, Gert; Cremer, Jonathan; More

Inflammatory Bowel Diseases. 19(2):246-253, February 2013.

Influence of Adalimumab Treatment on Anastomotic Strength, Degree of Inflammation, and Collagen Formation: An Experimental Study on the Small Intestine of Rabbits

Ploug, Thomas; Andersen, Kristian; Hansen, Katrine; More

Inflammatory Bowel Diseases. 19(2):254-258, February 2013.

Effect of Tumor Necrosis Factor-α Blockade on Mucosal Addressin Cell-adhesion Molecule-1 in Crohn's Disease

Biancheri, Paolo; Di Sabatino, Antonio; Rovedatti, Laura; More

Inflammatory Bowel Diseases. 19(2):259-264, February 2013.

Enhanced Expression of CXCL10 in Inflammatory Bowel Disease: Potential Role of Mucosal Toll-like Receptor 3 Stimulation

Østvik, Ann E.; Granlund, Atle vB; Bugge, Marit; More

Inflammatory Bowel Diseases. 19(2):265-274, February 2013.

Farnesoid X Receptor Expression Is Decreased in Colonic Mucosa of Patients with Primary Sclerosing Cholangitis and Colitis-associated Neoplasia

Torres, Joana; Bao, Xiuliang; Iuga, Alina C.; More

Inflammatory Bowel Diseases. 19(2):275-282, February 2013.

Topical Treatment with the Toll-like Receptor Agonist DIMS0150 Has Potential for Lasting Relief of Symptoms in Patients with Chronic Active Ulcerative Colitis by Restoring...

Musch, Eugen; Lutfi, Tamim; von Stein, Petra; More

Inflammatory Bowel Diseases. 19(2):283-292, February 2013.

Extracorporeal Photopheresis (ECP) in Patients with Steroid-dependent Crohn's Disease: An Open-label, Multicenter, Prospective Trial

Reinisch, Walter; Knobler, Robert; Rutgeerts, Paul J.; More

Inflammatory Bowel Diseases. 19(2):293-300, February 2013.

Older Age Is Associated with Higher Rate of Discontinuation of Anti-TNF Therapy in Patients with Inflammatory Bowel Disease

Desai, Amit; Zator, Zachary A.; de Silva, Punyanganie; More

Inflammatory Bowel Diseases. 19(2):309-315, February 2013.

Fecal MMP-9: A New Noninvasive Differential Diagnostic and Activity Marker in Ulcerative Colitis

Annaházi, Anita; Molnár, Tamás; Farkas, Klaudia; More

Inflammatory Bowel Diseases. 19(2):316-320, February 2013.

Lectin-based Immunoassay for Aberrant IgG Glycosylation as the Biomarker for Crohn's Disease

Shinzaki, Shinichiro; Kuroki, Eri; Iijima, Hideki; More

Inflammatory Bowel Diseases. 19(2):321-331, February 2013.

Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes

Schoepfer, Alain M.; Beglinger, Christoph; Straumann, Alex; More

Inflammatory Bowel Diseases. 19(2):332-341, February 2013.

Adenomas in Patients with Inflammatory Bowel Disease Are Associated with an Increased Risk of Advanced Neoplasia

van Schaik, Fiona D.M.; Mooiweer, Erik; van der Have, Mike; More

Inflammatory Bowel Diseases. 19(2):342-349, February 2013.

Comparison of High Definition with Standard White Light Endoscopy for Detection of Dysplastic Lesions During Surveillance Colonoscopy in Patients with Colonic Inflammatory Bowel...

Subramanian, Venkataraman; Ramappa, Vidyasagar; Telakis, Emmanouil; More

Inflammatory Bowel Diseases. 19(2):350-355, February 2013.

Safety and Effectiveness of Long-term Allopurinol–Thiopurine Maintenance Treatment in Inflammatory Bowel Disease

Hoentjen, Frank; Seinen, Margien L.; Hanauer, Stephen B.; More

Inflammatory Bowel Diseases. 19(2):363-369, February 2013.

Atypical Disease Phenotypes in Pediatric Ulcerative Colitis: 5-year Analyses of the EUROKIDS Registry

Levine, Arie; de Bie, Charlotte I.; Turner, Dan; More

Inflammatory Bowel Diseases. 19(2):370-377, February 2013.

Disease Phenotype at Diagnosis in Pediatric Crohn's Disease: 5-year Analyses of the EUROKIDS Registry

de Bie, Charlotte I.; Paerregaard, Anders; Kolacek, Sanja; More

Inflammatory Bowel Diseases. 19(2):378-385, February 2013.

Epidemiological Risk Factors in Microscopic Colitis: A Prospective Case–Control Study

Fernández-Bañares, Fernando; de Sousa, Monia R.; Salas, Antonio; More

Inflammatory Bowel Diseases. 19(2):411-417, February 2013.

Human Herpesvirus 8-Associated Colorectal Kaposi's Sarcoma Occurring in a Drug-induced Immunocompromised Patient with Refractory Ulcerative Colitis: Report of a New Case and...

Pioche, Mathieu; Boschetti, Gilles; Cotte, Eddy; More

Inflammatory Bowel Diseases. 19(2):E12-E15, February 2013.

Plasma Gamma-Glutamyltransferase (GGT) Activity in Inflammatory Bowel Disease: Is the Clinical Laboratory Plasma GGT Assay Sensitive Enough for Gastroenterology?

Franzini, Maria; Fierabracci, Vanna; Bolognesi, Valeria; More

Inflammatory Bowel Diseases. 19(2):E21-E22, February 2013.

Potential Oncogenic Properties of Mobilized Stem Cells in a Subpopulation of Inflammatory Bowel Disease Patients Infected with Helicobacter pylori

Kapetanakis, Nikolaos; Kountouras, Jannis; Zavos, Christos; More

Inflammatory Bowel Diseases. 19(2):E27-E29, February 2013.

1 2 3 4 5